Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hamed Khalili, M.D.

Co-Author

This page shows the publications co-authored by Hamed Khalili and Ashwin Ananthakrishnan.
Connection Strength

11.260
  1. Alcohol Consumption is Associated With An Increased Risk of Microscopic Colitis: Results From 2 Prospective US Cohort Studies. Inflamm Bowel Dis. 2021 Sep 02.
    View in: PubMed
    Score: 0.246
  2. Ultra-processed Foods and Risk of Crohn's Disease and Ulcerative Colitis: A Prospective Cohort Study. Clin Gastroenterol Hepatol. 2021 Aug 28.
    View in: PubMed
    Score: 0.246
  3. Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease. Cell Host Microbe. 2021 Aug 11; 29(8):1294-1304.e4.
    View in: PubMed
    Score: 0.244
  4. Dietary Gluten Intake Is Not Associated With Risk of Inflammatory Bowel Disease in US Adults Without Celiac Disease. Clin Gastroenterol Hepatol. 2021 Mar 26.
    View in: PubMed
    Score: 0.239
  5. Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2021 01 19; 27(2):155-161.
    View in: PubMed
    Score: 0.236
  6. Immune-mediated diseases and risk of Crohn's disease or ulcerative colitis: a prospective cohort study. Aliment Pharmacol Ther. 2021 03; 53(5):598-607.
    View in: PubMed
    Score: 0.234
  7. Assessment of Body Weight Changes in Patients with Inflammatory Bowel Diseases Initiating Biologic Therapy: A Prospective Cohort Study. Dig Dis Sci. 2020 12; 65(12):3672-3678.
    View in: PubMed
    Score: 0.227
  8. Dietary Inflammatory Potential and Risk of Crohn's Disease and Ulcerative Colitis. Gastroenterology. 2020 09; 159(3):873-883.e1.
    View in: PubMed
    Score: 0.224
  9. Alterations in Fecal Microbiomes and Serum Metabolomes of Fatigued Patients With Quiescent Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2021 03; 19(3):519-527.e5.
    View in: PubMed
    Score: 0.222
  10. Longitudinal Trajectory of Fatigue With Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study. J Crohns Colitis. 2020 Mar 13; 14(3):309-315.
    View in: PubMed
    Score: 0.222
  11. Healthy Lifestyle Is Associated With Reduced Mortality in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2021 01; 19(1):87-95.e4.
    View in: PubMed
    Score: 0.222
  12. Low-dose Methotrexate has Similar Outcomes to High-dose Methotrexate in Combination with Anti-TNF Therapy in Inflammatory Bowel Diseases. J Crohns Colitis. 2019 Aug 14; 13(8):990-995.
    View in: PubMed
    Score: 0.213
  13. Correction: Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women Without Celiac Disease: A Prospective Cohort Study. Am J Gastroenterol. 2019 05; 114(5):837.
    View in: PubMed
    Score: 0.209
  14. Second-Look Endoscopy in Hospitalized Severe Ulcerative Colitis: A Retrospective Cohort Study. Inflamm Bowel Dis. 2019 03 14; 25(4):750-755.
    View in: PubMed
    Score: 0.207
  15. Cancer risk in microscopic colitis: a retrospective cohort study. BMC Gastroenterol. 2019 Jan 05; 19(1):1.
    View in: PubMed
    Score: 0.205
  16. Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women without Celiac Disease: A Prospective Cohort Study. Am J Gastroenterol. 2019 01; 114(1):127-134.
    View in: PubMed
    Score: 0.204
  17. Obesity and Weight Gain Since Early Adulthood Are Associated With a Lower Risk of Microscopic Colitis. Clin Gastroenterol Hepatol. 2019 11; 17(12):2523-2532.e1.
    View in: PubMed
    Score: 0.203
  18. IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn's Disease. Inflamm Bowel Dis. 2018 09 15; 24(10):2247-2257.
    View in: PubMed
    Score: 0.200
  19. The role of diet in the aetiopathogenesis of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2018 09; 15(9):525-535.
    View in: PubMed
    Score: 0.200
  20. Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study. Gastroenterology. 2018 12; 155(6):1764-1775.e2.
    View in: PubMed
    Score: 0.199
  21. Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative Colitis. Inflamm Bowel Dis. 2018 07 12; 24(8):1840-1848.
    View in: PubMed
    Score: 0.198
  22. Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative Colitis. Dig Dis Sci. 2018 10; 63(10):2740-2746.
    View in: PubMed
    Score: 0.197
  23. Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis. Clin Gastroenterol Hepatol. 2019 02; 17(3):502-509.e1.
    View in: PubMed
    Score: 0.197
  24. Smoking is Associated with an Increased Risk of Microscopic Colitis: Results From Two Large Prospective Cohort Studies of US Women. J Crohns Colitis. 2018 Apr 27; 12(5):559-567.
    View in: PubMed
    Score: 0.195
  25. Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases. J Crohns Colitis. 2018 Apr 27; 12(5):525-531.
    View in: PubMed
    Score: 0.195
  26. Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study. Inflamm Bowel Dis. 2017 11; 23(11):1898-1904.
    View in: PubMed
    Score: 0.189
  27. Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis. 2017 07; 23(7):1088-1095.
    View in: PubMed
    Score: 0.184
  28. Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases. . 2017 May 10; 21(5):603-610.e3.
    View in: PubMed
    Score: 0.182
  29. Genetic risk factors for serious infections in inflammatory bowel diseases. Scand J Gastroenterol. 2017 May; 52(5):570-576.
    View in: PubMed
    Score: 0.179
  30. Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2017 02; 23(2):283-288.
    View in: PubMed
    Score: 0.179
  31. Erratum to: Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases. Dig Dis Sci. 2017 02; 62(2):552.
    View in: PubMed
    Score: 0.179
  32. Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease. Inflamm Bowel Dis. 2017 01; 23(1):82-88.
    View in: PubMed
    Score: 0.178
  33. Identification and Characterization of a Novel Association between Dietary Potassium and Risk of Crohn's Disease and Ulcerative Colitis. Front Immunol. 2016; 7:554.
    View in: PubMed
    Score: 0.177
  34. Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases. Dig Dis Sci. 2017 01; 62(1):197-206.
    View in: PubMed
    Score: 0.176
  35. Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn's Disease. Am J Gastroenterol. 2016 12; 111(12):1816-1822.
    View in: PubMed
    Score: 0.174
  36. Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations: A Cohort Study. Inflamm Bowel Dis. 2016 09; 22(9):2149-57.
    View in: PubMed
    Score: 0.174
  37. HBV/HIV coinfection is associated with poorer outcomes in hospitalized patients with HBV or HIV. J Viral Hepat. 2016 10; 23(10):820-9.
    View in: PubMed
    Score: 0.171
  38. Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes. Dig Dis Sci. 2016 09; 61(9):2627-35.
    View in: PubMed
    Score: 0.170
  39. Zinc intake and risk of Crohn’s disease and ulcerative colitis: a prospective cohort study. Int J Epidemiol. 2015 Dec; 44(6):1995-2005.
    View in: PubMed
    Score: 0.165
  40. Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis. Aliment Pharmacol Ther. 2016 Jan; 43(1):52-60.
    View in: PubMed
    Score: 0.164
  41. Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease. Inflamm Bowel Dis. 2015 Oct; 21(10):2304-2310.
    View in: PubMed
    Score: 0.163
  42. High School Diet and Risk of Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis. 2015 Oct; 21(10):2311-9.
    View in: PubMed
    Score: 0.163
  43. Endogenous levels of circulating androgens and risk of Crohn's disease and ulcerative colitis among women: a nested case-control study from the nurses' health study cohorts. Inflamm Bowel Dis. 2015 Jun; 21(6):1378-85.
    View in: PubMed
    Score: 0.159
  44. New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2015 May; 41(10):972-9.
    View in: PubMed
    Score: 0.157
  45. High C-Reactive Protein Is Associated with Poor Sleep Quality Independent of Nocturnal Symptoms in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2015 Jul; 60(7):2136-43.
    View in: PubMed
    Score: 0.156
  46. Measures of obesity and risk of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2015 Feb; 21(2):361-8.
    View in: PubMed
    Score: 0.156
  47. Early life environment and natural history of inflammatory bowel diseases. BMC Gastroenterol. 2014 Dec 16; 14:216.
    View in: PubMed
    Score: 0.155
  48. Natural history of perianal Crohn's disease after fecal diversion. Inflamm Bowel Dis. 2014 Dec; 20(12):2260-5.
    View in: PubMed
    Score: 0.154
  49. Sleep duration affects risk for ulcerative colitis: a prospective cohort study. Clin Gastroenterol Hepatol. 2014 Nov; 12(11):1879-86.
    View in: PubMed
    Score: 0.148
  50. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. BMJ. 2013 Nov 14; 347:f6633.
    View in: PubMed
    Score: 0.143
  51. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology. 2013 Nov; 145(5):970-7.
    View in: PubMed
    Score: 0.140
  52. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut. 2014 May; 63(5):776-84.
    View in: PubMed
    Score: 0.140
  53. Early life factors and risk of inflammatory bowel disease in adulthood. Inflamm Bowel Dis. 2013 Mar; 19(3):542-7.
    View in: PubMed
    Score: 0.136
  54. Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health Study. Clin Gastroenterol Hepatol. 2013 Jan; 11(1):57-62.
    View in: PubMed
    Score: 0.132
  55. Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Gastroenterology. 2012 Nov; 143(5):1199-1206.
    View in: PubMed
    Score: 0.131
  56. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut. 2013 Aug; 62(8):1153-9.
    View in: PubMed
    Score: 0.129
  57. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med. 2012 Mar 06; 156(5):350-9.
    View in: PubMed
    Score: 0.127
  58. Geographical variation and incidence of inflammatory bowel disease among US women. Gut. 2012 Dec; 61(12):1686-92.
    View in: PubMed
    Score: 0.126
  59. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology. 2012 Mar; 142(3):482-9.
    View in: PubMed
    Score: 0.125
  60. Plasma concentrations of perfluoroalkyl substances and risk of inflammatory bowel diseases in women: A nested case control analysis in the Nurses' Health Study cohorts. Environ Res. 2021 Oct 16; 112222.
    View in: PubMed
    Score: 0.062
  61. Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence. Dig Dis Sci. 2020 01; 65(1):111-118.
    View in: PubMed
    Score: 0.053
  62. Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis. Cell. 2019 07 25; 178(3):714-730.e22.
    View in: PubMed
    Score: 0.053
  63. Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020 04; 18(4):872-880.e1.
    View in: PubMed
    Score: 0.053
  64. Implementing Dietary Modifications and Assessing Nutritional Adequacy of Diets for Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2019 Mar; 15(3):133-144.
    View in: PubMed
    Score: 0.052
  65. Does Obesity Influence the Risk of Clostridium difficile Infection Among Patients with Ulcerative Colitis? Dig Dis Sci. 2018 09; 63(9):2445-2450.
    View in: PubMed
    Score: 0.049
  66. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med. 2017 Nov 28; 9(1):103.
    View in: PubMed
    Score: 0.047
  67. Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2016 06; 14(6):818-824.e6.
    View in: PubMed
    Score: 0.042
  68. Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort. Inflamm Bowel Dis. 2015 Dec; 21(12):2879-85.
    View in: PubMed
    Score: 0.041
  69. Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis. 2014 Feb; 20(2):398-415.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.